A randomized, double-blind, active controlled, vehicle-controlled, subject initiated study comparing efficacy and safety of ME-609 [aciclovir/hydrocortisone; Lipsovir; Medivir AB] versus acyclovir cream for treatment of recurrent Herpes simplex labialis.
Latest Information Update: 28 Oct 2015
At a glance
- Drugs Aciclovir/hydrocortisone (Primary) ; Aciclovir
- Indications Herpes labialis; Oral ulcer
- Focus Registrational; Therapeutic Use
- 17 Jan 2011 Primary endpoint 'Disease-recurrence' has been met
- 17 Jan 2011 Primary endpoint 'Recurrence-of-infection' has been met
- 14 Sep 2009 Results were presented at the 49th ACAAC meeting in San Francisco, California, USA.